Add in stabilised disease ... who presented the data at WCLC. On safety, there was a case of interstitial lung disease (ILD), a side effect that has been seen with other ADCs using Daiichi ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...